Ansun BioPharma

Ansun BioPharma

CA - San Diego
Pharmaceutical

Focus: Anti-virals

Ansun BioPharma is a life sciences company focused on Anti-virals.

Neurology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

DAS181
COVID-19
N/A
Clinical Trials (1)
NCT04324489DAS181 for Severe COVID-19: Compassionate Use
N/A
DAS181 dry powder, formulation F02
Asthma
Phase 1
Clinical Trials (1)
NCT01113034A Safety Trial of DAS181 (FludaseĀ®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis
Phase 1
DAS181
Influenza
Phase 1
Clinical Trials (1)
NCT00527865Single Dose Escalating Study of DAS181 in Adults
Phase 1
DAS181
Healthy
Phase 1
Clinical Trials (1)
NCT00876161DAS181 Single Dose Escalation Study in Healthy Adults
Phase 1
DAS181 dry powder, formulation F02
Parainfluenza
Phase 2
Clinical Trials (1)
NCT01644877A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen
Phase 2
DAS181-F02 Dry Powder in Bulk
Parainfluenza
Phase 2
Clinical Trials (1)
NCT01924793An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection
Phase 2
Phase 2
Clinical Trials (1)
NCT04298060DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)
Phase 2
DAS181-F02 formulation
Influenza
Phase 2
Clinical Trials (1)
NCT01740063Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza
Phase 2
DAS181 dry powder, formulation F02
Influenza
Phase 2
Clinical Trials (1)
NCT01037205Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza
Phase 2
DAS181
COVID-19
Phase 2/3
Clinical Trials (1)
NCT04354389DAS181 for STOP COVID-19
Phase 2/3
Clinical Trials (1)
NCT03808922Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Phase 3

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2011
Portfolio: 11 clinical trials
Top TAs: Infectious Diseases, Respiratory
Publications: 10 in PubMed
Therapeutic Area Focus
Respiratory
2 pipeline
Marketed
Pipeline